CEO James McGorry of Biostage, Inc., (OTCQB: BSTG) returns to the show to discuss 2019 plans to transition into a clinical company, investment into the Chinese market, and spreading their technology to those in need.

advanced and tested # biotechnology company # bronchi # Connecticut Children’s Medical Center # esophagus # Mayo Clinic # method of addressing organ damage # natural healing process # tissue engineering and cell biology # trachea # Asia # China # investors